Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adaptive Equipment Systems (AES) was a specialized developer and manufacturer of automated laboratory equipment for the life sciences and drug discovery sectors. The company focused on high-performance liquid handling systems and custom robotic integrations designed to streamline high-throughput screening and genomic research workflows. Its product line featured the AES-2000 and AES-1000 automated liquid handlers, which were recognized for their precision and reliability in complex laboratory environments. In July 2005, Adaptive Equipment Systems was acquired by Molecular Devices Corporation to bolster its automated drug discovery and liquid handling portfolio. Following the acquisition, AES's technology was integrated into the Molecular Devices suite of products, contributing to advancements in microplate processing and automated assay development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adaptive Equipment Systems.